You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Infectious Disease Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 5 of 5

Cooperative Re-Engagement Controlled Trial (CoRECT)

Daniel Skiest, MD
HIV, Infection

Baystate Infectious Diseases Clinical Research
3300 Main Street
Springfield, MA 01199

Recruiting

GEMINI 1 - A Phase III multicenter trial evaluating the efficacy, safety, and tolerability of dolutegravir plus lamivudine (study drugs) compared to dolutegravir plus tenofovir/emtricitabine in HIV-1

The purpose of this study is to compare safety, efficacy, and tolerability of a two drug regimen of dolutegravir (DTG) plus (+) lamivudine (3TC) administered once daily to the DTG plus Tenofovir [TDF]/Emtricitabine [FTC] fixed dose combination [FDC] administered once daily in human immunodeficiency virus (HIV) 1 infected adult subjects that have not previously received antiretroviral therapy. The study is designed to demonstrate the non-inferior antiviral activity of DTG plus 3TC regimen to that of DTG plus TDF/FTC FDC.
Dr. Daniel Skiest
Infection, HIV

Baystate Medical Center, 759 Chestnut Street, Springfield, MA

INSIGHT Genomics Study to collect DNA of people with the flu

The purpose of this study is to obtain DNA of people who may have the flu in order to better understand the gene response to those that have a high risk of getting the flu.

Armando Paez, MD
Infection

Baystate Infectious Diseases Clinical Research
3300 Main Street
Springfield, MA 01199

Recruiting

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Armando Paez, MD
Infection

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Recruiting

Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults

Durane Walker, MD
HIV, Infection

Baystate Infectious Diseases Clinical Research, 3300 Main Street, Springfield, MA

Active
Page 1 of 1 | Results 1 - 5 of 5